8 years ago

Calcivis Secures Funding for US Expansion

  • Calcivis, a UK-based medical devices company focused on innovating the management of tooth decay, has secured a new equity funding round of undisclosed amount

  • The company intends to use the funds to support commercialization steps including UK launch to dental practices and Pre-Market Authorisation (PMA) filing with the FDA before the end of 2017 in anticipation of early 2019 launch in the US

  • Calcivis provides an imaging system that enables the assessment and management of demineralization associated with dental caries and erosion.

      • ProblemHealthcare

      "Tooth decay is a common problem that can lead to pain, infection, and tooth loss. Current methods for detecting and managing tooth decay are often unreliable and time-consuming."

      Solution

      "Calcivis has developed an imaging system that uses a proprietary technology to visualize calcium ions released from demineralizing tooth surfaces. This allows dentists to detect and monitor tooth decay in real-time, enabling them to develop personalized treatment plans and prevent further damage."

      Covered on